Need2Know Headlines

Lower Out-of-Pocket Cost on Insulin

Some financial relief is coming for diabetics around the US. The United Health Care announced today eight more insulin products will be available for reimbursement limiting the out of pocket cost to $35 or less insulin products from Eli Lily, Novo, Nordisk and Sanofi have been given preferred status. The changes are effective for the first of the year and apply to all sh short and rapid acting insulin from these manufacturers and these companies control about 90% of the total insulin market in the US.